Clinical Trial Update: Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the interleukin-6 receptor antagonist tocilizumab for hand osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Osteoarthritis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hand Osteoarthritis | Phase 3 | Status: COMPLETED